Sara Baptista da Silva

Sara Baptista da Silva is a Researcher at the Centre for Biotechnology and Fine Chemistry (CBQF) at the Catholic University of Portugal (UCP). She holds a PhD in Pharmaceutical Sciences from the University of Porto, specializing in Pharmaceutical Technology. Her research focuses on biomedical applications of bio-based materials, including drug delivery systems, wound healing, and sustainable nanotechnology. She has contributed to over 80 publications, 2 patents, and led projects such as B4Brain and TEX4WOUND, emphasizing circular economy principles.

Educations: PhD in Pharmaceutical Sciences (University of Porto, 2015), Master’s in Applied Microbiology (UCP, 2009), Bachelor’s in Microbiology (UCP, 2007).

Research Interests: Her work integrates nanotechnology, biomaterials, and sustainable practices to address biomedical challenges. Key areas include chitosan-based systems for hemodialysis, antimicrobial agents in skincare, and neuroprotective strategies for neurodegenerative diseases. She advocates for green technologies, utilizing industrial by-products to create value-added biomedical solutions.

Awards: CBQF-UCP Merit Award (2021–2023), FULBRIGHT Prize (2023), and multiple productivity incentives. Active in editorial roles (Frontiers in Pharmacology) and professional associations.

Grants & Labs: Involved in projects funded by FCT and industry collaborations, including partnerships with the University of Porto and University of Pernambuco. Co-founder of Blendera® (COHiTEC award recipient). Supervised 3 MSc theses and over 35 student projects.